D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge
Immunology
Australia
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 166 Citations 116,672 619 World Ranking 14 National Ranking 1
Medicine D-index 175 Citations 122,715 706 World Ranking 149 National Ranking 3
Best Scientists D-index 187 Citations 138,618 788 World Ranking 333 National Ranking 7

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

2022 - Research.com Medicine in Australia Leader Award

2022 - Research.com Immunology in Australia Leader Award

2017 - Fellow of the Australian Academy of Science

1995 - Gottschalk Medal, Australian Academy of Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cancer

Mark J. Smyth mainly investigates Immunology, Immune system, Cancer research, Immunotherapy and Cancer. His Interleukin 12 research extends to Immunology, which is thematically connected. His Interleukin 12 study combines topics from a wide range of disciplines, such as Perforin, Natural killer cell, Antigen-presenting cell and Cell biology.

His Cancer research research incorporates themes from Tumor necrosis factor alpha, CD8, Interferon gamma, Adoptive cell transfer and Disease. His work deals with themes such as Melanoma, Cytokine and Oncology, which intersect with Immunotherapy. His Cancer study combines topics in areas such as Cell type, Immunity and Mechanism of action.

His most cited work include:

  • Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
  • Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
  • Natural Innate and Adaptive Immunity to Cancer (1288 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Cancer research, Immune system, Cytotoxic T cell and Immunotherapy. His work on Cancer expands to the thematically related Immunology. His study in Cancer research is interdisciplinary in nature, drawing from both Immune checkpoint, T cell, Adoptive cell transfer and Receptor.

His studies in Cytotoxic T cell integrate themes in fields like Molecular biology and T lymphocyte. He combines subjects such as Cytokine and Oncology with his study of Immunotherapy. His work carried out in the field of Interleukin 21 brings together such families of science as Antigen-presenting cell, IL-2 receptor and Cell biology.

He most often published in these fields:

  • Immunology (75.43%)
  • Cancer research (44.04%)
  • Immune system (43.40%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (44.04%)
  • Immune system (43.40%)
  • Immunotherapy (33.09%)

In recent papers he was focusing on the following fields of study:

Mark J. Smyth spends much of his time researching Cancer research, Immune system, Immunotherapy, Cancer and Immunology. His Cancer research research is multidisciplinary, incorporating elements of Immune checkpoint, Cytotoxic T cell, CD8 and Cancer immunotherapy. His Immune system study incorporates themes from Tumor necrosis factor alpha and Antigen.

The Immunotherapy study combines topics in areas such as T cell, Adjuvant, Oncology and Melanoma. His studies examine the connections between Cancer and genetics, as well as such issues in Adenosine, with regards to Adenosine receptor. His Immunology study integrates concerns from other disciplines, such as Metastasis and Disease.

Between 2016 and 2021, his most popular works were:

  • Cancer immunoediting and resistance to T cell-based immunotherapy. (287 citations)
  • Cancer immunoediting and resistance to T cell-based immunotherapy. (287 citations)
  • Targeting immunosuppressive adenosine in cancer (258 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

His primary areas of study are Cancer research, Immune system, Immunology, Immunotherapy and Cancer. His research integrates issues of Immune checkpoint, T cell, Cytotoxic T cell, TIGIT and Cancer immunotherapy in his study of Cancer research. His biological study spans a wide range of topics, including Natural killer cell and Receptor.

As part of one scientific family, Mark J. Smyth deals mainly with the area of Immunology, narrowing it down to issues related to the Oncology, and often Phases of clinical research and Pembrolizumab. The concepts of his Immunotherapy study are interwoven with issues in Cytokine, Immunosuppression, Downregulation and upregulation, Melanoma and Drug resistance. His Cancer research includes elements of Adenosine and Adenosine receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Robert D. Schreiber;Lloyd J. Old;Mark J. Smyth;Mark J. Smyth.
Science (2011)

4370 Citations

Natural Innate and Adaptive Immunity to Cancer

Matthew D. Vesely;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth.
Annual Review of Immunology (2011)

1768 Citations

Immune surveillance of tumors.

Jeremy B. Swann;Mark J. Smyth.
Journal of Clinical Investigation (2007)

1499 Citations

Functional significance of the perforin/granzyme cell death pathway

Joseph A. Trapani;Mark J. Smyth.
Nature Reviews Immunology (2002)

1368 Citations

Adaptive immunity maintains occult cancer in an equilibrium state

Catherine M. Koebel;William Vermi;William Vermi;Jeremy B. Swann;Jeremy B. Swann;Nadeen Zerafa.
Nature (2007)

1366 Citations

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric.
Nature Medicine (2009)

1337 Citations

NKT cells: what's in a name?

Dale I Godfrey;H Robson MacDonald;Mitchell Kronenberg;Mark J Smyth.
Nature Reviews Immunology (2004)

1308 Citations

NKT cells: facts, functions and fallacies

Dale I. Godfrey;Kirsten J.L. Hammond;Lynn D. Poulton;Mark J. Smyth.
Immunology Today (2000)

1050 Citations

New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

Deepak Mittal;Matthew M Gubin;Robert D Schreiber;Mark J Smyth;Mark J Smyth.
Current Opinion in Immunology (2014)

1001 Citations

Differential tumor surveillance by natural killer (NK) and NKT cells

Mark J. Smyth;Kevin Y. T. Thia;Shayna E.A. Street;Erika Cretney.
Journal of Experimental Medicine (2000)

975 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark J. Smyth

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 345

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 220

Joseph A. Trapani

Joseph A. Trapani

Peter MacCallum Cancer Centre

Publications: 190

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 181

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 158

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 141

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 136

Phillip K. Darcy

Phillip K. Darcy

Peter MacCallum Cancer Centre

Publications: 126

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 122

Ricky W. Johnstone

Ricky W. Johnstone

Peter MacCallum Cancer Centre

Publications: 117

Hideo Yagita

Hideo Yagita

Juntendo University

Publications: 115

Mitchell Kronenberg

Mitchell Kronenberg

La Jolla Institute For Allergy & Immunology

Publications: 111

Geoffrey R. Hill

Geoffrey R. Hill

Fred Hutchinson Cancer Research Center

Publications: 110

Dale I. Godfrey

Dale I. Godfrey

University of Melbourne

Publications: 106

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 105

Jérôme Galon

Jérôme Galon

Université Paris Cité

Publications: 105

Trending Scientists

Michael Mitzenmacher

Michael Mitzenmacher

Harvard University

Aijun An

Aijun An

York University

Bernard S. Renger

Bernard S. Renger

AT&T (United States)

Hongzhang Zhang

Hongzhang Zhang

Dalian Institute of Chemical Physics

Guodong Zhang

Guodong Zhang

InterDigital (United States)

Franz Winter

Franz Winter

TU Wien

Jing-Li Luo

Jing-Li Luo

University of Alberta

Takasuke Matsuo

Takasuke Matsuo

Osaka University

Subhash Mahajan

Subhash Mahajan

University of California, Davis

Sung Hee Baek

Sung Hee Baek

Seoul National University

Louis Lebel

Louis Lebel

Chiang Mai University

Ronald W. Harvey

Ronald W. Harvey

United States Geological Survey

Debomoy K. Lahiri

Debomoy K. Lahiri

Indiana University

Barry W. Feig

Barry W. Feig

The University of Texas MD Anderson Cancer Center

Neil Barnes

Neil Barnes

GlaxoSmithKline (United Kingdom)

Something went wrong. Please try again later.